arset="UTF-8" /> Novo Nordisk successfully completes diabetes drug phase 3a trial | Local Healthcare
Ad Code

Weight Management Program

Isn’t it time you kicked your weight problems out of your life? You deserve to feel good, look good, and have excellent health just like everyone else. Call us today at (520) 885-2822 to get started on the new you!.

COPENHAGEN (Reuters) – Danish pharmaceutical company Novo Nordisk has successfully completed the second phase 3a trial with its diabetes drug semaglutide, it said on Friday. “We are excited about these trial results, which show that 1.0 mg semaglutide injected once weekly provided better glycaemic control and greater weight loss than 2.0 mg exenatideonce-weekly,” chief science officer Mads Krogsgaard Thomsen said in a statement. Novo Nordisk said semaglutide appeared to have a safe and well-tolerated profile. (Reporting by Teis Jensen; editing by David Clarke)

Call us TODAY!

520-885-2822

Get Started Today!

Error: Contact form not found.

Local Healthcare Staffing

Local Healthcare Staffing

We specialize in the full time, part time, and Locum Tenens. At Local Healthcare Staffing we recruit qualified, dedicated and motivated medical staff for all specialties and modalities. Our Clients range from large to small specialist clinics to large hospitals and medical facilities.